Ozempic Maker Novo Nordisk to Cut 9,000 Jobs Amid Rising Competition
Novo Nordisk, the Danish pharmaceutical company behind blockbuster weight-loss drugs Ozempic and Wegovy, has announced plans to cut 9,000 jobs, representing 11% of its global workforce. The move comes just weeks after the firm warned of slowing profit growth as cheaper rival products enter the booming weight-loss drug market. The layoffs mark the first major…